{
  "references": "24 Pfrommer L, Diexer S, Klee B, et al. Post-COVID Recovery is More Likely after an Infection with\nthe SARS-CoV-2 Omicron Variant: A Population-Based Cohort Study. Available at SSRN:\nhttps://ssrn.com/abstract=4774405 or http://dx.doi.org/10.2139/ssrn.4774405\n25 Hampshire A, Azor A, Atchison C, et al. Cognition and Memory after Covid-19 in a Large\nCommunity Sample. N Engl J Med. 2024;390(9):806-818. doi:10.1056/NEJMoa2311330\n\n26 Brannock MD, Chew RF, Preiss AJ, et al. Long COVID Risk and Pre-COVID Vaccination: An EHR-\nBased Cohort Study from the RECOVER Program. Preprint. medRxiv.\n\n2022;2022.10.06.22280795. Published 2022 Oct 7. doi:10.1101/2022.10.06.22280795\n27 Di Fusco M, Sun X, Allen KE, et al. Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine\nagainst Long COVID Symptoms: A US Nationwide Study. Vaccines (Basel). 2024;12(2):183.\nPublished 2024 Feb 11. doi:10.3390/vaccines12020183\n28 De Domenico M. Prevalence of long COVID decreases for increasing COVID-19 vaccine uptake.\nPLOS Glob Public Health. 2023 Jun 21;3(6):e0001917. doi: 10.1371/journal.pgph.0001917.\nPMID: 37342998; PMCID: PMC10284420.\n29 Mirin, A. A. A preliminary estimate of the economic impact of long COVID in the United States.\nFatigue: Biomedicine, Health &amp; Behavior, 2022; 10(4), 190–199.\nhttps://doi.org/10.1080/21641846.2022.2124064\n30 Reuschke, D., & Houston, D. (2023). The impact of Long COVID on the UK workforce. Applied\nEconomics Letters, 30(18), 2510–2514. https://doi.org/10.1080/13504851.2022.2098239"
}
